2.1. Study design
The design of the study was a 2-arm blank controlled trial with baseline variables (ratio, 1:1). The study was approved by the Shaanxi Provincial Hospital of Chinese Medicine Ethics Committee for Clinical Research (Ethics Approval Number: (2019) Ethics Review No. 26) and there were no modifications to the protocol after the initiation of the study.